英夫利昔单抗治疗重度溃疡性结肠炎及后续的新型冠状病毒肺炎：一石二鸟。 - Suppr

Infliximab for severe ulcerative colitis and subsequent SARS-CoV-2 pneumonia: a stone for two birds.

作者信息

Bezzio Cristina, Manes Gianpiero, Bini Francesco, Pellegrini Lucienne, Saibeni Simone

机构信息

Gastroenterology Unit, ASST Rhodense, Garbagnate Milanese, Italy

Gastroenterology Unit, ASST Rhodense, Garbagnate Milanese, Italy.

出版信息

Gut. 2021 Mar;70(3):623-624. doi: 10.1136/gutjnl-2020-321760. Epub 2020 Jun 17.

DOI:10.1136/gutjnl-2020-321760

PMID:32554621

Abstract

摘要

相似文献

Infliximab for severe ulcerative colitis and subsequent SARS-CoV-2 pneumonia: a stone for two birds.

Gut. 2021 Mar;70(3):623-624. doi: 10.1136/gutjnl-2020-321760. Epub 2020 Jun 17.

SARS-CoV-2 (COVID-19) pneumonia patient treated with two doses of infliximab within 2 weeks for acute severe ulcerative colitis: A case report.

Medicine (Baltimore). 2022 Jan 28;101(4):e28722. doi: 10.1097/MD.0000000000028722.

Induction of remission with tacrolimus in a patient with severe acute, cortisone refractory ulcerative colitis and severe Covid-19 pneumonia: a case report.

BMC Gastroenterol. 2022 Jan 15;22(1):22. doi: 10.1186/s12876-022-02094-3.

Intensification of maintenance therapy with infliximab in ulcerative colitis.

Rev Esp Enferm Dig. 2015 Sep;107(9):525-6.

Antibody responses to SARS-CoV-2 infection are attenuated in infliximab-treated patients with IBD.

Nat Rev Gastroenterol Hepatol. 2021 May;18(5):286. doi: 10.1038/s41575-021-00445-1.

Infliximab Efficacy and Safety in an Ulcerative Colitis Patient with Systemic Lupus Erythematosus.

J Crohns Colitis. 2016 Jun;10(6):752-3. doi: 10.1093/ecco-jcc/jjw034. Epub 2016 Jan 30.

Immune thrombocytopenia in ulcerative colitis.

Tech Coloproctol. 2016 Jul;20(7):499-500. doi: 10.1007/s10151-016-1471-1. Epub 2016 Apr 30.

An older patient with active ulcerative colitis and coronavirus disease 2019 (COVID-19) pneumonia successfully treated with the combination of anti-TNFα therapy and azathioprine.

Clin J Gastroenterol. 2023 Apr;16(2):187-192. doi: 10.1007/s12328-022-01737-y. Epub 2022 Nov 23.

Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative Colitis.

Inflamm Bowel Dis. 2019 Jun 18;25(7):1169-1186. doi: 10.1093/ibd/izy383.

Etrolizumab versus infliximab in the treatment of induction phase of ulcerative colitis: A systematic review and indirect comparison.

Pharmacol Res. 2019 Jan;139:120-125. doi: 10.1016/j.phrs.2018.11.003. Epub 2018 Nov 3.

引用本文的文献

Prevalence and complication of COVID-19 in patients with ankylosing spondylitis (AS) and its relationship with TNF-a inhibitors.

Immun Inflamm Dis. 2023 Jun;11(6):e915. doi: 10.1002/iid3.915.

Tocilizumab-coated solid lipid nanoparticles loaded with cannabidiol as a novel drug delivery strategy for treating COVID-19: A review.

Front Immunol. 2023 Mar 22;14:1147991. doi: 10.3389/fimmu.2023.1147991. eCollection 2023.

Delayed cutaneous hypersensitivity reactions following the use of infliximab or adalimumab in patients with coronavirus disease 2019.

J Med Virol. 2023 Feb;95(2):e28518. doi: 10.1002/jmv.28518.

Management of Ulcerative Colitis Flare-Ups in the Era of COVID-19.

Cureus. 2022 Dec 3;14(12):e32153. doi: 10.7759/cureus.32153. eCollection 2022 Dec.

I've looked at gut from both sides now: Gastrointestinal tract involvement in the pathogenesis of SARS-CoV-2 and HIV/SIV infections.

Front Immunol. 2022 Aug 12;13:899559. doi: 10.3389/fimmu.2022.899559. eCollection 2022.

Risks of SARS-CoV-2 Infection and Immune Response to COVID-19 Vaccines in Patients With Inflammatory Bowel Disease: Current Evidence.

Front Immunol. 2022 Jun 23;13:933774. doi: 10.3389/fimmu.2022.933774. eCollection 2022.

Impact of biologics and small molecules for inflammatory bowel disease on COVID-19-related hospitalization and mortality: A systematic review and meta-analysis.

JGH Open. 2022 Mar 20;6(4):241-250. doi: 10.1002/jgh3.12728. eCollection 2022 Apr.

Clinical progress of therapeutics and vaccines: Rising hope against COVID-19 treatment.

Process Biochem. 2022 Jul;118:154-170. doi: 10.1016/j.procbio.2022.04.011. Epub 2022 Apr 14.

Targeting TNF-α for COVID-19: Recent Advanced and Controversies.

Front Public Health. 2022 Feb 11;10:833967. doi: 10.3389/fpubh.2022.833967. eCollection 2022.

Therapeutic role of immunomodulators during the COVID-19 pandemic- a narrative review.

Postgrad Med. 2022 Mar;134(2):160-179. doi: 10.1080/00325481.2022.2033563. Epub 2022 Feb 12.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Infliximab for severe ulcerative colitis and subsequent SARS-CoV-2 pneumonia: a stone for two birds.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献